Correlation between rest-activity rhythm and survival in cancer patients experiencing pain

References

• Beck SL, Schwartz AL, Towsley G, et al. (2004). Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manage. 27:140–8
   PubMed Web of Science ®Google Scholar
• Carpenter JS, Andrykowski MA. (1998). Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res. 45:5–13
   PubMed Web of Science ®Google Scholar
• Deadwyler SA, Porrino L, Siegel JM, Hampson RE. (2007). Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates. J Neurosci. 27:14239–47
   PubMed Web of Science ®Google Scholar
• Dijk DJ, Czeisler CA. (1995). Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves and sleep spindle activity in humans. J Neurosci. 15:3526–38
   PubMed Web of Science ®Google Scholar
• Evers PD, Logan JE, Sills V, Chin AI. (2014). Karnofsky Performance Status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma. World J Urol. 32:385–91
   PubMed Web of Science ®Google Scholar
• Filipski E, King VM, Li X, et al. (2003). Disruption of circadian coordination accelerates malignant growth in mice. Pathol Biol. 51:216–19
   PubMed Web of Science ®Google Scholar
• Given B, Given CW, Sikorskii A, et al. (2008). Establishing mild, moderate and severe scores for cancer-related symptoms: How consistent and clinically meaningful are interference-based severity cut-points? J Pain Symptom Manage. 35:126–35
   PubMed Web of Science ®Google Scholar
• Grambsch PM, Therneau TM. (1994). Proportional hazards tests in diagnostics based on weighted residuals. Biometrika. 81:515–26
   Web of Science ®Google Scholar
• Granda TG, Lévi F. (2002). Tumor-based rhythms of anticancer efficacy in experimental models. Chronobiol Int. 19:21–41
   PubMed Web of Science ®Google Scholar
• Grutsch JF, Wood PA, Du-Quiton J, et al. (2011). Validation of actigraphy to assess circadian organization and sleep quality in patients with advanced lung cancer. J Circadian Rhythms. 9:4. doi: 10.1186/1740-3391-9-4
   PubMedGoogle Scholar
• Hartsell WF, Desilvio M, Bruner DW, et al. (2008). Can physicians accurately predict survival time in patients with metastatic cancer? Analysis of RTOG 97-14. J Palliat Med. 11:723–8
   PubMed Web of Science ®Google Scholar
• Innominato PF, Focan C, Gorlia T, et al. (2009a). Circadian rhythm in rest and activity: A biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res. 69:4700–7
   PubMed Web of Science ®Google Scholar
• Innominato PF, Mormont MC, Rich TA, et al. (2009b). Circadian disruption, fatigue, and anorexia clustering in advanced cancer patients: Implications for innovative therapeutic approaches. Integr Cancer Ther. 8:361–70
   PubMed Web of Science ®Google Scholar
• Innominato PF, Giacchetti S, Bjarnason GA, et al. (2012). Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer. Int J Canc. 131:2684–92
   PubMed Web of Science ®Google Scholar
• Kumar SP. (2011). Utilization of brief pain inventory as an assessment tool for pain in patients with cancer: A focused review. Indian J Palliat Care. 17:108–15
   PubMedGoogle Scholar
• Lévi F, Okyar A, Dulong S, et al. (2010). Circadian timing in cancer treatments. Ann Rev Pharmacol Toxicol. 50:377–421
   PubMed Web of Science ®Google Scholar
• Ma CL, Chang WP, Lin CC. (2014). Rest/activity rhythm is related to the coexistence of pain and sleep disturbance among advanced cancer patients with pain. Support Care Cancer. 22:87–94
   PubMed Web of Science ®Google Scholar
• Miller AH, Ancoli-Israel S, Bower JE, et al. (2008). Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol. 26:971–82
   PubMed Web of Science ®Google Scholar
• Minsky BD, Pajak TF, Ginsberg RJ, et al. (2002). INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol. 20:1167–74
   PubMed Web of Science ®Google Scholar
• Moldawer LL, Copeland III EM. (1997). Proinflammatory cytokines, nutritional support, and the cachexia syndrome: Interactions and therapeutic options. Cancer. 79:1828–39
   PubMed Web of Science ®Google Scholar
• Mor V, Laliberte L, Morris JN, Wiemann M. (1984). The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer. 53:2002–7
   PubMed Web of Science ®Google Scholar
• Mormont MC, Langouët AM, Claustrat B, et al. (2002). Marked rhythms of circadian system function: A study of patients with metastatic colorectal cancer and good performance status. Chronobiol Int. 19:141–55
   PubMed Web of Science ®Google Scholar
• Mormont MC, Waterhouse J, Bleuzen P, et al. (2000). Marked 24-h rest/activity rhythms are associated with better quality of life, better responses, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res. 6:3038–45
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. (2006). Physician data query cancer information summaries. National Cancer Institute. Available from: http://www.nci.nih.gov/cancerinfo/pdq/treatment/non-small-cell-lung//healthprofessional [last accessed 22 July 2013]
   Google Scholar
• Nieder C, Marienhagen K, Geinitz H, Grosu AL. (2011). Can current prognostic scores reliably guide treatment decisions in patients with brain metastases from malignant melanoma? J Cancer Res Ther. 7:47–51
   PubMed Web of Science ®Google Scholar
• Ortiz-Tudela E, Iurisci I, Beau J, et al. (2014). The circadian rest-activity rhythm, a potential safety pharmacology endpoint of cancer chemotherapy. Int J Cancer. 134:2717–25
   PubMed Web of Science ®Google Scholar
• Partl R, Richtig E, Avian A, et al. (2013). Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma. Int J Radiat Oncol Biol Phys. 85:662–6
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Touitou Y, Smolensky M. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911–29
   PubMed Web of Science ®Google Scholar
• Rich T, Innominato PF, Boerner J, et al. (2005). Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res. 11:1757–64
   PubMed Web of Science ®Google Scholar
• Robinson DW Jr, Eisenberg DF, Cella D, et al. (2008). The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia. J Support Oncol. 6:283–90
   PubMedGoogle Scholar
• Roché H, Conte P, Perez EA, et al. (2011). Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: A pooled analysis by performance status of efficacy and safety data from 2 phase III studies. Breast Cancer Res Treat. 125:755–65
   PubMed Web of Science ®Google Scholar
• Saini A, Tucci M, Tampellini M, et al. (2013). Circadian variation of breakthrough pain in cancer patients. Eur J Pain. 17:264–70
   PubMed Web of Science ®Google Scholar
• Sarna L, Brecht ML. (1997). Dimensions of symptom distress in women with advanced lung cancer: A factor analysis. Heart Lung. 26:23–30
   PubMed Web of Science ®Google Scholar
• Schwartz JRL, Thomas R. (2008). Neurophysiology of sleep and wakefulness: Basic science and clinical implications. Curr Neuropharmacol. 6:367–78
   PubMed Web of Science ®Google Scholar
• Scott HR, McMillan DC, Forrest LM, et al. (2002). The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer. 87:264–7
   PubMed Web of Science ®Google Scholar
• Seow H, Barbera L, Sutradhar R, et al. (2011). Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. J Clin Oncol. 29:1151–8
   PubMed Web of Science ®Google Scholar
• Sephton S, Spiegel D. (2003). Circadian disruption in cancer: A neuroendocrine-immune pathway from stress to disease? Brain Behav Immun. 17:321–8
   PubMed Web of Science ®Google Scholar
• Serlin RC, Mendoza TR, Nakamura Y, et al. (1995). When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 61:277–84
   PubMed Web of Science ®Google Scholar
• Son GH, Chung S, Kim K. (2011). The adrenal peripheral clock: Glucocorticoid and the circadian timing system. Front Neuroendocrinol. 32:451–65
   PubMed Web of Science ®Google Scholar
• Spiegel D. (2012). Mind matters in cancer survival. Psychooncology. 21:588–93
   PubMed Web of Science ®Google Scholar
• Touitou Y, Lévi F, Bogdan A, et al. (1995). Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors. J Cancer Res Clin Oncol. 121:181–8
   PubMed Web of Science ®Google Scholar
• Tsujino N, Sakurai T. (2009). Orexin/hypocretin: A neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev. 61:162–76
   PubMed Web of Science ®Google Scholar
• Tzeng JI, Fu YW, Lin CC. (2012). Validity and reliability of the Taiwanese version of the Pittsburgh Sleep Quality Index in cancer patients. Int J Nurs Stud. 49:102–8
   PubMed Web of Science ®Google Scholar
• Verger E, Salamero M, Conill C. (1992). Can Karnofsky performance status be transformed to the Eastern Cooperative Oncology Group scoring scale and vice versa? Eur J Cancer. 28A:1328–30
   PubMed Web of Science ®Google Scholar
• Walsh D, Donnelly S, Rybicki L. (2000). The symptoms of advanced cancer: Relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer. 8:175–9
   PubMed Web of Science ®Google Scholar
• Wyatt JK, Ritz-De Cecco A, Czeisler CA, Dijk DJ. (1999). Circadian temperature and melatonin rhythms, sleep, and neurobehavioral function in humans living on a 20-h day. Am J Physiol. 277:R1152–63
   PubMed Web of Science ®Google Scholar
• Yamanaka A, Beuckmann CT, Willie JT, et al. (2003). Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron. 38:701–13
   PubMed Web of Science ®Google Scholar